Immunovant, Inc.IMVTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+13.1%
5Y CAGR+48.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+13.1%/yr
Annual compound
5Y CAGR
+48.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $713.97M | +12.4% |
| 2024 | $635.37M | +68.7% |
| 2023 | $376.53M | -23.8% |
| 2022 | $493.82M | +23.4% |
| 2021 | $400.15M | +297.9% |
| 2020 | $100.57M | +30844.9% |
| 2019 | $325000.00 | - |
| 2018 | $0.00 | - |